AdvanSix
Market Cap
US$491.3m
Last Updated
2020/01/23 01:09 UTC
Data Sources
Company Financials +
Executive Summary
AdvanSix Inc. manufactures and sells polymer resins.
Rewards
Risk Analysis
Snowflake Analysis
Fair value with mediocre balance sheet.
Similar Companies
Share Price & News
How has AdvanSix's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ASIX's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
6.3%
ASIX
0.3%
US Chemicals
0.8%
US Market
1 Year Return
-39.5%
ASIX
0.8%
US Chemicals
25.1%
US Market
Return vs Industry: ASIX underperformed the US Chemicals industry which returned 1.6% over the past year.
Return vs Market: ASIX underperformed the US Market which returned 24.7% over the past year.
Shareholder returns
| ASIX | Industry | Market | |
|---|---|---|---|
| 7 Day | 6.3% | 0.3% | 0.8% |
| 30 Day | -15.0% | -0.9% | 3.1% |
| 90 Day | -25.0% | 5.4% | 10.9% |
| 1 Year | -39.5%-39.5% | 16.5%0.8% | 27.7%25.1% |
| 3 Year | -31.6%-31.6% | 31.6%6.6% | 51.3%41.6% |
| 5 Year | n/a | 51.2%19.2% | 77.2%57.6% |
Price Volatility Vs. Market
How volatile is AdvanSix's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall St
AdvanSix (NYSE:ASIX) Takes On Some Risk With Its Use Of Debt1 week ago | Simply Wall St
At US$16.24, Is It Time To Put AdvanSix Inc. (NYSE:ASIX) On Your Watch List?3 weeks ago | Simply Wall St
Is AdvanSix Inc.'s (NYSE:ASIX) P/E Ratio Really That Good?Valuation
Is AdvanSix undervalued compared to its fair value and its price relative to the market?
7.82x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate ASIX's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate ASIX's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: ASIX is good value based on its PE Ratio (7.3x) compared to the Chemicals industry average (20.8x).
PE vs Market: ASIX is good value based on its PE Ratio (7.3x) compared to the US market (18.9x).
Price to Earnings Growth Ratio
PEG Ratio: ASIX is poor value based on its PEG Ratio (1.1x)
Price to Book Ratio
PB vs Industry: ASIX is good value based on its PB Ratio (1.1x) compared to the US Chemicals industry average (2.2x).
Next Steps
Future Growth
How is AdvanSix forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
6.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ASIX's forecast earnings growth (6.5% per year) is above the savings rate (1.7%).
Earnings vs Market: ASIX's earnings (6.5% per year) are forecast to grow slower than the US market (14.3% per year).
High Growth Earnings: ASIX's earnings are forecast to grow, but not significantly.
Revenue vs Market: ASIX's revenue (0.2% per year) is forecast to grow slower than the US market (7.6% per year).
High Growth Revenue: ASIX's revenue (0.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ASIX's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has AdvanSix performed over the past 5 years?
4.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ASIX has high quality earnings.
Growing Profit Margin: ASIX's current net profit margins (4.7%) are lower than last year (7.9%).
Past Earnings Growth Analysis
Earnings Trend: ASIX's earnings have grown by 4.8% per year over the past 5 years.
Accelerating Growth: ASIX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ASIX had negative earnings growth (-45.5%) over the past year, making it difficult to compare to the Chemicals industry average (-17%).
Return on Equity
High ROE: ASIX's Return on Equity (15.4%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is AdvanSix's financial position?
Financial Position Analysis
Short Term Liabilities: ASIX's short term assets ($290.3M) exceed its short term liabilities ($286.7M).
Long Term Liabilities: ASIX's short term assets ($290.3M) do not cover its long term liabilities ($507.9M).
Debt to Equity History and Analysis
Debt Level: ASIX's debt to equity ratio (63.8%) is considered high.
Reducing Debt: Insufficient data to determine if ASIX's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: ASIX's debt is well covered by operating cash flow (55%).
Interest Coverage: ASIX's interest payments on its debt are well covered by EBIT (17.8x coverage).
Balance Sheet
Inventory Level: ASIX has a high level of physical assets or inventory.
Debt Coverage by Assets: ASIX's debt is covered by short term assets (assets are 1.1x debt).
Next Steps
Dividend
What is AdvanSix's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate ASIX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ASIX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ASIX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ASIX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ASIX's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of AdvanSix's salary, the management and board of directors tenure and is there insider trading?
4.0yrs
Average management tenure
CEO
Erin Kane (42yo)
4yrs
Tenure
US$3,250,079
Compensation
Ms. Erin N. Kane has been Independent Director of Chemours Company since June 18, 2019. Ms. Kane has been the Chief Executive Officer of AdvanSix Inc. since 2016 and serves as its President. Ms. Kane serve ...
CEO Compensation Analysis
Compensation vs Market: Erin's total compensation ($USD3.25M) is above average for companies of similar size in the US market ($USD1.70M).
Compensation vs Earnings: Erin's compensation has been consistent with company performance over the past year.
Management Age and Tenure
4.0yrs
Average Tenure
49yo
Average Age
Experienced Management: ASIX's management team is considered experienced (4 years average tenure).
Board Age and Tenure
3.3yrs
Average Tenure
54yo
Average Age
Experienced Board: ASIX's board of directors are considered experienced (3.3 years average tenure).
Insider Trading
Insider Buying: ASIX insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 5,000 |
| Max Price | US$19.74 |
| Entity | Individual |
| Role | Chairman of the Board Independent Chairman |
| Shares | 5,100 |
| Max Price | US$19.74 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 5,000 |
| Max Price | US$20.28 |
| Entity | Individual |
| Role | Chairman of the Board Independent Chairman |
| Shares | 4,350 |
| Max Price | US$21.34 |
| Entity | Individual |
| Role | Chairman of the Board Independent Chairman |
| Shares | 3,700 |
| Max Price | US$26.99 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 4,000 |
| Max Price | US$27.37 |
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Management Team
John Quitmeyer (68yo)
Senior VP
- Tenure: 4yrs
- Compensation: US$1.50m
Erin Kane (42yo)
CEO, President & Director
- Tenure: 4yrs
- Compensation: US$3.25m
Christopher Gramm (49yo)
VP & Controller
- Tenure: 3.3yrs
- Compensation: US$614.85k
Jonathan Bellamy (53yo)
Chief Human Resources Officer & Senior VP
- Compensation: US$773.50k
Michael Preston (47yo)
CFO & Senior VP
- Tenure: 4yrs
- Compensation: US$1.18m
Adam Kressel
Director of Investor Relations
Board Members
Dan Sansone (67yo)
Independent Director
- Tenure: 3.3yrs
- Compensation: US$185.04k
Paul Huck (69yo)
Independent Director
- Tenure: 3.3yrs
- Compensation: US$190.04k
Mike Marberry (61yo)
Independent Chairman
- Tenure: 3.3yrs
- Compensation: US$240.04k
Darrell Hughes (54yo)
Independent Director
- Tenure: 3.3yrs
- Compensation: US$170.04k
Todd Karran (54yo)
Independent Director
- Tenure: 3.3yrs
- Compensation: US$170.04k
Sharon Spurlin (53yo)
Independent Director
- Tenure: 3.3yrs
- Compensation: US$180.04k
Erin Kane (42yo)
CEO, President & Director
- Tenure: 4yrs
- Compensation: US$3.25m
Company Information
AdvanSix Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: AdvanSix Inc.
- Ticker: ASIX
- Exchange: NYSE
- Founded: 2016
- Industry: Commodity Chemicals
- Sector: Materials
- Market Cap: US$491.257m
- Shares outstanding: 27.91m
- Website: https://www.AdvanSix.com
Number of Employees
Location
- AdvanSix Inc.
- 300 Kimball Drive
- Suite 101
- Parsippany
- New Jersey
- 7054
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ASIX | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Sep 2016 |
| 960 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Sep 2016 |
| ASIX * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Sep 2016 |
Biography
AdvanSix Inc. manufactures and sells polymer resins. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce engineered plastics, fibers, filaments, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone, which is used by customers in the production of adhesives, paints, coatings, solvents, herbicides, and other engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, cyclohexanol, acetaldehyde oxime, 2-pentanone oxime, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors in North America, South America, and internationally. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/01/23 01:09 |
| End of Day Share Price | 2020/01/22 00:00 |
| Earnings | 2019/09/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.